Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4679-2 is a small, single-stranded, non-coding RNA molecule in humans. MicroRNAs regulate gene expression by binding to complementary sequences on target messenger RNAs (mRNAs), causing mRNA degradation or translational repression. The mature microRNA is encoded in the genome, processed from a primary transcript via a canonical biogenesis pathway that includes Drosha and Dicer enzymes, and is loaded into the RNA-induced silencing complex (RISC). Thousands of microRNAs, including MIR4679-2, exist in humans, each potentially playing roles in the fine-tuning of gene expression and cellular homeostasis. Many well-studied microRNAs are involved in critical biological pathways—such as cell cycle control, apoptosis, cancer progression, and developmental patterning. While some microRNAs serve as disease biomarkers or therapeutic targets, there is no evidence that microRNA 4679-2 currently fulfills those roles. Manipulation of microRNAs is an active area of biomedical research with potential future clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4679-2 (MIR4679-2).